Allergan

From Wikipedia, the free encyclopedia

Allergan, Inc. <tr><td colspan="2" style="text-align:center; padding:16px 0 16px 0;">Image:Allergan.png</td></tr>
Type	Public (NYSE: AGN)
Founded	1948
Headquarters	Irvine, California <tr><th style="text-align:right; padding-right:0.75em;">Key people</th><td>David E.I. Pyott, Chairman of the Board, CEO Michael Ball, President</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Industry</th><td>Pharmaceuticals</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Products</th><td>Botox, Acular, Alocril, Prevage, Avage, Tazorac</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Revenue</th><td>$2.319 billion USD] (Image:Green Arrow Up.svg $29.1M FY 2005)</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Employees</th><td>5,055</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Website</th><td>www.allergan.com</td></tr>

Allergan, Inc. is a global specialty pharmaceutical company. Their product ranges include ophthalmic pharmaceuticals, dermatology products, and neurological products. The company's most notable neurologic product is Botox, used around the world to treat a variety of debilitating disorders associated with muscle overactivity and also well-known -- under the tradenames Botox Cosmetic and Vistabel -- for the treatment of facial lines.

In March 2006, Allergan acquired aesthetic company, Inamed, to create a world leading aesthetic franchise focused on facial aesthetics, breast aesthetics, and devices designed to treat obesity.